Krzywkowski Karen, Jensen Anders A, Connolly Christopher N, Bräuner-Osborne Hans
Faculty of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark.
Pharmacogenet Genomics. 2007 Apr;17(4):255-66. doi: 10.1097/FPC.0b013e3280117269.
The serotonin [5-hydroxytryptamine (5-HT)]-gated ion channel 5-HT3 is involved in the mediation of postoperative and radiotherapy/chemotherapy-induced nausea/emesis and in irritable bowel syndrome. It has also been suggested to play a role in various psychiatric diseases. Five naturally occurring single nucleotide polymorphisms leading to amino acid changes have been identified in the human 5-HT3A gene.
We investigated the functional effects of these polymorphisms on the 5-HT3A receptor using fluorescence-based cellular assays. Notably, variants A33T, S253N, and M257I displayed 5-HT-induced maximal responses of 3-64% of the wild-type response, whereas R344H and P391R exhibited wild-type-like function. All variants displayed wild-type-like potencies of 5-HT and three 5-HT3 antagonists. Furthermore, all variants displayed Kd values similar to that of the wild-type receptor in a [H]GR65630-binding assay. The surface expression of A33T, M257I, and R344H was reduced 2-4-fold compared with the wild-type, despite similar total expression levels. Finally, coexpression of wild-type 5-HT3A or 5-HT3B subunits with 5-HT3A variants A33T, S253N, or M257I resulted in mixed or heteromeric receptors, characterized by significantly reduced maximal responses to 5-HT compared with the wild-type receptors.
Three polymorphisms of the 5-HT3A gene gave rise to functionally impaired receptors whose function could not be rescued by either wild-type 5-HT3A or 5-HT3B. Three of the variant receptors were surface-expressed at reduced levels in spite of total expression levels similar to wild-type, indicating that these variants affect receptor biogenesis and/or trafficking. These severe single nucleotide polymorphism effects hold promise for identification of new 5-HT3A gene-disease causalities.
5-羟色胺[5-羟色胺(5-HT)]门控离子通道5-HT3参与介导术后及放疗/化疗引起的恶心/呕吐以及肠易激综合征。也有研究表明其在多种精神疾病中发挥作用。在人类5-HT3A基因中已鉴定出五个导致氨基酸改变的天然存在的单核苷酸多态性。
我们使用基于荧光的细胞分析方法研究了这些多态性对5-HT3A受体的功能影响。值得注意的是,A33T、S253N和M257I变体显示5-HT诱导的最大反应为野生型反应的3%至64%,而R344H和P391R表现出类似野生型的功能。所有变体对5-HT和三种5-HT3拮抗剂均表现出类似野生型的效价。此外,在[H]GR65630结合试验中,所有变体的解离常数(Kd)值与野生型受体相似。与野生型相比,A33T、M257I和R344H的表面表达降低了2至4倍,尽管总表达水平相似。最后,野生型5-HT3A或5-HT3B亚基与5-HT3A变体A33T、S253N或M257I共表达产生了混合或异源受体,其特征是与野生型受体相比,对5-HT的最大反应显著降低。
5-HT3A基因的三个多态性导致受体功能受损,野生型5-HT3A或5-HT3B均无法挽救其功能。尽管总表达水平与野生型相似,但其中三个变体受体的表面表达水平降低,表明这些变体影响受体的生物合成和/或转运。这些严重的单核苷酸多态性效应有望用于识别新的5-HT3A基因与疾病的因果关系。